BioNTech SE
BNTX
$89.27
-$0.04-0.05%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -958.16% | 92.35% | -0.27% | -258.18% | 27.01% |
| Total Depreciation and Amortization | -126.22% | 150.86% | 28.51% | 76.05% | -47.59% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 2,013.70% | 177.31% | -772.82% | 115.94% | 74.36% |
| Change in Net Operating Assets | -135.16% | 23.54% | 239.05% | 40.61% | 0.60% |
| Cash from Operations | -60.53% | 448.95% | 120.24% | -66.36% | 29.69% |
| Capital Expenditure | -75.29% | -36.46% | 40.23% | 27.51% | 11.30% |
| Sale of Property, Plant, and Equipment | -79.40% | 497.43% | 7.85% | -29.48% | 126.26% |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -226.71% | -2,331.68% | -102.97% | 101.63% | 1,037.01% |
| Cash from Investing | -193.30% | -1,380.08% | -105.57% | 102.88% | 513.98% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -65.22% | 13.53% | 3.62% | -89.04% | 7.59% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -23.81% | 10.93% | -3.94% | -86.62% | 10.40% |
| Foreign Exchange rate Adjustments | 106.48% | -340.74% | 161.63% | -216.87% | 673.33% |
| Miscellaneous Cash Flow Adjustments | 1,045.08% | -84.39% | 153.92% | -5.09% | -130.75% |
| Net Change in Cash | -1,263.04% | -315.03% | -78.43% | 204.15% | 117.70% |